This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Complications of the combined oral contraceptive pill

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • increased mortality due to pulmonary embolism, cerebral thrombosis, myocardial infarction; smoking habit and age are the principal determinants:
    • no excess mortality if non-smoker & < 35 years
    • excess mortality of 10 per 100,000 woman years if smoker and < 35 years
    • excess mortality of 15 per 100,000 if non-smoker and > 35 years
    • excess mortality of 50 per 100,000 if smoker and > 35 years

  • thromboembolism - oestrogen increases platelet count and adhesiveness, and reduces anti-thrombin; the low oestrogen content of modern combined pills has made deep vein thrombosis and pulmonary embolism rare, but progestogen only pills are advised if there is pre-existing heart disease

  • metabolic - reduced glucose tolerance; increased levels of serum corticosteroid binding protein and thyroxine; progesterone increases LDL's and reduces HDL's, so increasing risk of stroke and myocardial infarction

  • hypertension - increased release of hepatic renin precursors

  • increased risk of gallbladder disease in susceptible patients

  • cancer - effect on breast / cervical cancer. There is an association between use of the combined oral contraceptive and cervical cancer. The risk of breast cancer is described in the linked item

  • menstruation - some women develop amenorrhoea, especially if cycles were previously irregular; no delay / acceleration of onset of menopause

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.